09966.HK
Alphamab Oncology
HKSE · Healthcare · Biotechnology · CN
HKD 8.77
−1.02%Next report
Analyst consensus
- Next report date
- Mar 30, 2027
- EPS estimate
- -HKD 0.31
- Revenue estimate
- HKD 124.3M
Latest reported
- Last report date
- Aug 27, 2026
- EPS actual
- -HKD 0.05
- EPS estimate
- -HKD 0.43
- Revenue actual
- —
- Revenue estimate
- HKD 4.4M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 1
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +89.4%
- Revenue beats (12Q)
- —
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Mar 30, 2027